OvaCure was honoured to present at the 12th Biennial Ovarian Cancer Research Symposium in September at the University of Washington in Seattle.
A keynote presentation by doctor Marie-Claire King, the first to identify the BRCA1, 3 days Symposium, over 370 participants, 4 sessions guiding us through the most important aspects of ovarian cancer: detection and prevention, genomics and molecular mechanism, tumor microenvironment and immunology, novel therapeutics- response and resistance.
Among others, OvaCure attended the panel "Role Of Advocates In Ovarian Cancer Research" and learned about the critical role of patient’s advocacy in securing funding.
Our sincerest thank you to the patients advocates for your great work! and thank you to Rivkin Center for Ovarian Cancer and the American Association for Cancer Research for giving us the precious chance to be part of this event and to help us reaching OvaCure's vision: curing ovarian cancer together.